Part 1/8:
The Impact of Federal Job Cuts on Public Health: Insights from Former FDA Commissioner Robert Califf
The current Trump administration has ignited a significant controversy surrounding public health due to its approach to federal employment, particularly within health agencies like the FDA. Notably, many agency heads are publicly resisting directives from higher-ups, undermining stringent demands for justifications of federal positions made by figures such as Elon Musk. This increasing pushback raises concerns about the implications of massive staff cuts occurring throughout health agencies at a time when public health is facing severe challenges.